Concepedia

Publication | Open Access

Early outcomes of exon 11 mutants in GIST treated with standard dose Imatinib

DOIFull Paper Access

16

Citations

20

References

2017

Year

Anant Ramaswamy, Munita Bal, Rohit Swami, Omshree Shetty, Subhadeep Bose, Trupti Pai, Mamta Gurav, Sudeep Gupta, Vikas Ostwal
Annals of Translational Medicine

Abstract

In patients with GIST exon 11 codon 557-558 mutation subset there is a trend towards an inferior survival even when treated with imatinib mesylate (IM).

References

YearCitations

Page 1